Home / Inspections / 1099225

FDA Inspection 1099225 — Biomat USA, Inc

Biomat USA, Inc — FEI 1643692

The FDA completed an inspection of Biomat USA, Inc on July 17, 2019 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 17, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)

Facility

Other inspections at this facility

  • 1020802 (NAI Fri Jul 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 928180 (NAI Sat May 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 840365 (NAI Mon Jul 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 728252 (NAI Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 582367 (NAI Fri May 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources